Cargando…

Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics

SUMMARY: Chemoprophylaxis has been recommended for plastic surgery patients judged to be at increased risk for venous thromboembolism. Several investigators have encountered this complication in patients despite anticoagulation therapy. An increased rate of complications related to postoperative ble...

Descripción completa

Detalles Bibliográficos
Autor principal: Swanson, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173821/
https://www.ncbi.nlm.nih.gov/pubmed/25289217
http://dx.doi.org/10.1097/GOX.0b013e318299fa26
_version_ 1782336266968236032
author Swanson, Eric
author_facet Swanson, Eric
author_sort Swanson, Eric
collection PubMed
description SUMMARY: Chemoprophylaxis has been recommended for plastic surgery patients judged to be at increased risk for venous thromboembolism. Several investigators have encountered this complication in patients despite anticoagulation therapy. An increased rate of complications related to postoperative bleeding has been reported. This article examines the efficacy and safety of this intervention, along with ethical considerations, in an attempt to determine whether any benefits of chemoprophylaxis justify the additional risks. The statistical methods and conclusion of the Venous Thromboembolism Prevention Study are challenged. Other preventative measures that do not cause negative side effects are discussed as safer alternatives.
format Online
Article
Text
id pubmed-4173821
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-41738212014-10-06 Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics Swanson, Eric Plast Reconstr Surg Glob Open Special Topic SUMMARY: Chemoprophylaxis has been recommended for plastic surgery patients judged to be at increased risk for venous thromboembolism. Several investigators have encountered this complication in patients despite anticoagulation therapy. An increased rate of complications related to postoperative bleeding has been reported. This article examines the efficacy and safety of this intervention, along with ethical considerations, in an attempt to determine whether any benefits of chemoprophylaxis justify the additional risks. The statistical methods and conclusion of the Venous Thromboembolism Prevention Study are challenged. Other preventative measures that do not cause negative side effects are discussed as safer alternatives. Wolters Kluwer Health 2013-07-08 /pmc/articles/PMC4173821/ /pubmed/25289217 http://dx.doi.org/10.1097/GOX.0b013e318299fa26 Text en Copyright © 2013 American Society of Plastic Surgeons—Global Open http://creativecommons.org/licenses/by-nc-nd/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Special Topic
Swanson, Eric
Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
title Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
title_full Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
title_fullStr Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
title_full_unstemmed Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
title_short Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
title_sort chemoprophylaxis for venous thromboembolism prevention: concerns regarding efficacy and ethics
topic Special Topic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173821/
https://www.ncbi.nlm.nih.gov/pubmed/25289217
http://dx.doi.org/10.1097/GOX.0b013e318299fa26
work_keys_str_mv AT swansoneric chemoprophylaxisforvenousthromboembolismpreventionconcernsregardingefficacyandethics